Farther Finance Advisors’s Y-mAbs Therapeutics YMAB Stock Holding History

Farther Finance Advisors’s Portfolio YMAB Stock Details YMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1	Closed	-$5	–	5095
2025 Q2	$5	Sell	1 -1,997	-100%	-$8.98K	﹤0.01%	4469
2025 Q1	$8.99K	Buy	1,998 +1,997	+199,700%	+$11.6K	﹤0.01%	2791
2024 Q4	$8	Hold	1	–	–	﹤0.01%	3970
2024 Q3	$13	Hold	1	–	–	﹤0.01%	3941
2024 Q2	$12	Hold	1	–	–	﹤0.01%	3778
2024 Q1	$16	Hold	1	–	–	﹤0.01%	3547
2023 Q4	$7	Buy	+1	New	+$6	﹤0.01%	3520

Other funds holding YMAB

BIG

Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors's YMAB Position: Q3 2025 in Review

Farther Finance Advisors sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 1 share — an estimated $5 sold.

Farther Finance Advisors first reported a position in YMAB in Q4 2023 and held it in 7 quarters. The position peaked at $8.99K in Q1 2025. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

Farther Finance Advisors reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
Farther Finance Advisors sold 1 Y-mAbs Therapeutics share in Q3 2025, an estimated $5.
Farther Finance Advisors first reported a position in Y-mAbs Therapeutics in Q4 2023 and held it in 7 quarters.
Farther Finance Advisors's Y-mAbs Therapeutics position peaked at $8.99K in Q1 2025.
2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on Farther Finance Advisors's 13F filing for Q3 2025, filed 14 Oct 2025.